HUMA
Humacyte, Inc.
NASDAQ · USHealthcareBiotechnology
$0.64-3.91%
Price as of Jul 20, 2026
HUMA ownership
Humacyte, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
39/100
Buys (3m)
2
Sells (3m)
2
Net (3m)
-$22.5K
Insiders buyingCluster buying
Insider trades by month Buys Sells
Sep
Nov
Dec
Apr
Aug
May
Context3-month price +20.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 12, 2026 | Windham-Bannister Susan Richardsdirector | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Constantino Michael T.director | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Wallace Max N.director | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Dougan Brady Wdirector | Grant | 0 | $1.08 |
| Jun 12, 2026 | Niklason Laura Edirector, officer: President, CEO and Director | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Sebelius Kathleendirector | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Jones Keith Anthonydirector | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Green Charles Brucedirector | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Seimetz Dianedirector | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Bamforth John Philipdirector | Grant | 80,000 | $1.08 |
| Jun 12, 2026 | Brown Emery N.director | Grant | 80,000 | $1.08 |
| May 20, 2026 | Parikh Shamik Jofficer: Chief Medical Officer | Sell | 45,887 | $0.90 |
| May 20, 2026 | Constantino Michael T.director | Buy | 11,000 | $0.89 |
| May 20, 2026 | Sebelius Kathleendirector | Buy | 56,818 | $0.88 |
| May 20, 2026 | Sander Dale A.officer: CFO and Chief Corp. Dev. Off | Sell | 45,887 | $0.90 |
| Nov 17, 2025 | Niklason Laura Edirector, officer: President, CEO and Director | Grant | 311,100 | $1.23 |
| Nov 17, 2025 | Parikh Shamik Jofficer: Chief Medical Officer | Grant | 311,100 | — |
| Nov 17, 2025 | Sander Dale A.officer: CFO and Chief Corp. Deve. Off. | Grant | 311,100 | — |
| Nov 17, 2025 | Dougan Brady Wdirector | Grant | 311,100 | $1.23 |
| Aug 20, 2025 | Dougan Brady Wdirector | Sell | 1,100,000 | $1.63 |
| Aug 20, 2025 | Niklason Laura Edirector, officer: President, CEO and Director | Sell | 591,685 | $1.58 |
| Aug 20, 2025 | Dougan Brady Wdirector | Sell | 549,360 | $1.83 |
| Aug 20, 2025 | Niklason Laura Edirector, officer: President, CEO and Director | Sell | 1,100,000 | $1.63 |
| Aug 20, 2025 | Niklason Laura Edirector, officer: President, CEO and Director | Sell | 549,360 | $1.83 |
| Aug 20, 2025 | Dougan Brady Wdirector | Sell | 591,685 | $1.58 |
| Jun 16, 2025 | Seimetz Dianedirector | Grant | 80,000 | $2.41 |
| Jun 16, 2025 | Jones Keith Anthonydirector | Grant | 80,000 | $2.41 |
| Jun 16, 2025 | Brown Emery N.director | Grant | 80,000 | $2.41 |
| Jun 16, 2025 | Pope Todddirector | Grant | 80,000 | $2.41 |
| Jun 16, 2025 | Niklason Laura Edirector, officer: President, CEO and Director | Grant | 0 | $2.41 |
Source: HUMA SEC Form 4 filings, latest Jun 12, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their HUMA positions over the last 6 months (SEC Form 13F).
Increased
113
New positions
55
Reduced
74
Sold out
32
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 12.3M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 11.3M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 8.4M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7.2M | May 15, 2026 |
| ANTIPODES PARTNERS LTD | Increased | 5.7M | May 5, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 3.8M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 3.7M | Feb 9, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 3.7M | May 15, 2026 |
| STATE STREET CORP | Increased | 3.0M | May 15, 2026 |
| UBS GROUP AG | Increased | 3.0M | Jan 29, 2026 |
| STATE STREET CORP | Increased | 2.8M | Feb 13, 2026 |
| UBS GROUP AG | Reduced | 2.8M | May 5, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2.6M | Feb 17, 2026 |
| MORGAN STANLEY | Increased | 2.5M | Feb 13, 2026 |
| WOODLINE PARTNERS LP | Increased | 2.0M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.